$406.96
19.715.09%
Ult. Agg.: Nov 6, 5:42 PM
The average analyst price target for BeOne Medicines is $395.30, 3.3% below the current price. Of 16 analysts, 16 rate it Buy. Targets range from $311 to $465. The latest change came on Nov 6, 2026, when RBC Capital raised its price target on BeOne Medicines from $459 to $465 and kept an Outperform rating.
Price Target Range — 8 Quarters
Analyst Consensus — 16 Analysts
Rating Trend — Last 9 Months